期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Time-Opening Suprapubic Catheter versus Intermittent Catheter for Male Patients with Spinal Cord Injury (Spinal Level above Level C5)
1
作者 Hui Chen p. Tang +8 位作者 R. B. Ou J. W. Zeng m. p. huang Q. L. Liu Q. Q. Li J. B. huang T. H. huang Chonghe Jiang Keji Xie 《Open Journal of Urology》 2016年第9期154-157,共4页
Objective: To compare the short-time complications associated with time-opening suprapubic catheter (SPT) versus intermittent catheter (IC) in male patients with spinal cord injury (above level C5). Methods: A prospec... Objective: To compare the short-time complications associated with time-opening suprapubic catheter (SPT) versus intermittent catheter (IC) in male patients with spinal cord injury (above level C5). Methods: A prospective review of records was carried out to identify SCI patients managed with SPT or IC between 2011 and 2016. The complications included renal function (Serum creatinine), urinary tract infection (UTI), bladder stones, urethral complications, scrotal, and gross hematuria. Patients were followed at week 4, 3 and 6 months;the urodynamic assessment was repeated at 6 months. Results: A total of 30 patients (11 SPT, 19 IC) were recruited in this trial. There is no significant difference between the two catheter groups for the entire out-come. Scrotal abscesses and urethral stricture were only seen in patients with IC. Conclusions: SPT has similar urological complication with IC for SCI patients (above level C5) except the incidence of scrotal abscesses and urethral stricture. 展开更多
关键词 Suprapubic Catheter Intermittent Catheter Spinal Cord Injury
暂未订购
Therapeutic Outcome of Botulinum Toxin Type A for Patients with Low Bladder Compliance Secondary to Spinal Cord Injury 被引量:2
2
作者 H. Chen m. p. huang +6 位作者 T. H. huang C. H. Jiang J. W. Zeng L. L. Zhou Q. L. Liu Q. Q. Li X. Y. Yang 《Open Journal of Urology》 2017年第11期207-211,共5页
Objective: To evaluate the efficacy and safety of botulinum toxin type A (BTX-A) in treating patients with low bladder compliance (BC) secondary to spinal cord injury (SCI). Methods: From 2011 to 2016, we retrospected... Objective: To evaluate the efficacy and safety of botulinum toxin type A (BTX-A) in treating patients with low bladder compliance (BC) secondary to spinal cord injury (SCI). Methods: From 2011 to 2016, we retrospected patients who received BTX-A injections for LBC secondary to SCI. The primary outcomes were urodynamic parameters including maximum detrusor pressure (Pdetmax), bladder compliance (BC). Related adverse events were recorded. Results: 72 SCI patients were selected (62 males, 10 females, age range 18 - 52 years;mean age 28.5 years). 12 weeks after BTX-A injection, Pdetmax decreased from 51.02 cmH2O to 28.31 cmH2O. BC increased from 3.64 ml/cmH2O to 10.08 ml/cmH2O. 12 patients had mild transient haematuria for 1 - 2 days. Conclusion: Intradetrusor BTX-A injection was effective and safe for patients with low BC secondary to SCI. 展开更多
关键词 BOTULINUM TOXIN Type A LOW BLADDER Compliance Spinal CORD Injury
暂未订购
Clinical Nursing Recommendations for the Treatment of the BTX-A Injections Due to Neurological Detrusor Overactivity 被引量:2
3
作者 J. m. Lin Hui Chen +4 位作者 m. p. huang Q. L. Liu Q. Q. Li T. H. huang X. Y. Yang 《Open Journal of Urology》 2019年第6期102-105,共4页
Background: Neurological detrusor overactivity (NDO) is commonly associated with various neurogenic diseases. Botulinum toxin A (BTX-A) has been proposed as alternatives to traditional treatments. Objective: To summar... Background: Neurological detrusor overactivity (NDO) is commonly associated with various neurogenic diseases. Botulinum toxin A (BTX-A) has been proposed as alternatives to traditional treatments. Objective: To summarize the clinical experience of nursing care for the treatment of the Botulinum toxin A (BTX-A) injections due to neurological detrusor overactivity (NDO). Methods: We reviewed the data of 32 inpatients who received BTX-A injections between August 2014 to July 2016. Their mean age was 27.4 years old (range: 19 - 38). They were all on clean intermittent catheterization. All patients presented detrusor overactivity resistant to oral anticholinergic treatment. Results: There were significant difference between outcomes at baseline and week12 for Pdetmax (60.08 cmH2O vs. 28.04 cmH2O, P Conclusions: Patients were satisfied with the treatment and nursing by targeted perioperative nursing. 展开更多
关键词 BOTULINUM Toxin A NEUROLOGICAL DETRUSOR OVERACTIVITY Nursing Care
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部